mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.006 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.007 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.007 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.009 |
mRNA |
necrostatin-7 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.009 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.01 |